By LESLIE PICKER
Now that the merger between the pharmaceutical giants is dead, their bankers will receive about 10 percent of their fees, according to estimates.
Published: April 7, 2016 at 12:00AM
from NYT Business Day http://ift.tt/1SARL5N
from WordPress http://ift.tt/23i9sP2
via Hadi Aboukhater
No comments:
Post a Comment